Deog‐Yeon Jo

2.1k total citations
105 papers, 1.3k citations indexed

About

Deog‐Yeon Jo is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Deog‐Yeon Jo has authored 105 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 44 papers in Oncology and 35 papers in Genetics. Recurrent topics in Deog‐Yeon Jo's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Chemokine receptors and signaling (20 papers) and Acute Myeloid Leukemia Research (18 papers). Deog‐Yeon Jo is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Chemokine receptors and signaling (20 papers) and Acute Myeloid Leukemia Research (18 papers). Deog‐Yeon Jo collaborates with scholars based in South Korea, United States and Ethiopia. Deog‐Yeon Jo's co-authors include Shahin Rafii, Malcolm A.S. Moore, Hwan‐Jung Yun, Tsuneyoshi Hamada, Hyo Jin Lee, Samyong Kim, Ik‐Chan Song, Seong‐Woo Kim, Jin Seok Kim and Hyewon Ryu and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.

In The Last Decade

Deog‐Yeon Jo

99 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deog‐Yeon Jo South Korea 20 519 422 405 332 283 105 1.3k
Majid Kazmi United Kingdom 19 568 1.1× 424 1.0× 279 0.7× 376 1.1× 234 0.8× 39 1.4k
Ann Traynor United States 26 680 1.3× 403 1.0× 582 1.4× 401 1.2× 381 1.3× 63 2.1k
Scott T. Avecilla United States 14 911 1.8× 390 0.9× 321 0.8× 515 1.6× 383 1.4× 36 1.6k
JE Leonard United States 6 235 0.5× 481 1.1× 637 1.6× 280 0.8× 507 1.8× 10 1.8k
María Luz Sánchez Spain 17 276 0.5× 143 0.3× 538 1.3× 188 0.6× 430 1.5× 22 1.1k
Nicola Di Renzo Italy 24 531 1.0× 681 1.6× 275 0.7× 329 1.0× 631 2.2× 98 1.9k
Luigina Mollica Canada 15 1.0k 1.9× 158 0.4× 421 1.0× 709 2.1× 665 2.3× 53 1.9k
Judith Landman‐Parker France 17 262 0.5× 434 1.0× 291 0.7× 510 1.5× 155 0.5× 47 1.5k
Roberta Pacini Italy 15 390 0.8× 567 1.3× 535 1.3× 601 1.8× 520 1.8× 20 1.9k
María Díez‐Campelo Spain 28 1.3k 2.5× 353 0.8× 468 1.2× 548 1.7× 1.0k 3.6× 106 2.3k

Countries citing papers authored by Deog‐Yeon Jo

Since Specialization
Citations

This map shows the geographic impact of Deog‐Yeon Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deog‐Yeon Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deog‐Yeon Jo more than expected).

Fields of papers citing papers by Deog‐Yeon Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deog‐Yeon Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deog‐Yeon Jo. The network helps show where Deog‐Yeon Jo may publish in the future.

Co-authorship network of co-authors of Deog‐Yeon Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Deog‐Yeon Jo. A scholar is included among the top collaborators of Deog‐Yeon Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deog‐Yeon Jo. Deog‐Yeon Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jin Seok, Jun Ho Jang, Deog‐Yeon Jo, et al.. (2023). Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. Journal of Korean Medical Science. 38(41). e328–e328. 3 indexed citations
3.
Ryu, Hyewon, Ik‐Chan Song, Hyo Jin Lee, et al.. (2022). Volumetric Splenomegaly in Patients With Polycythemia Vera. Journal of Korean Medical Science. 37(11). e87–e87. 6 indexed citations
4.
Song, Ik‐Chan, Deog‐Yeon Jo, Hyeoung‐Joon Kim, et al.. (2021). Clinical features and outcomes of hypocellular acute myeloid leukemia in adults. Medicine. 100(1). e24185–e24185. 1 indexed citations
5.
Kwon, Jaeyul, Hyewon Ryu, Hyo Jin Lee, et al.. (2021). Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies. Hematology. 26(1). 96–102. 6 indexed citations
6.
Song, Ik‐Chan, Hyewon Ryu, Hyo Jin Lee, et al.. (2021). Pulmonary hypertension in patients with chronic myeloid leukemia. Medicine. 100(33). e26975–e26975. 2 indexed citations
7.
Kwon, Minsuk, Hoyoung Lee, Hyunsoo Cho, et al.. (2020). PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors. Clinical Cancer Research. 26(7). 1644–1655. 34 indexed citations
10.
Choi, Yoon Seok, Minsuk Kwon, Ik‐Chan Song, et al.. (2017). Immunologic Characterization of Tumor Antigen-Specific T Cells in Multiple Myeloma: Implication in Immune Checkpoint Blockade. Blood. 130. 4389–4389. 1 indexed citations
11.
Jang, Jun Ho, Jin Seok Kim, Sung‐Soo Yoon, et al.. (2016). Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. Journal of Korean Medical Science. 31(2). 214–214. 56 indexed citations
12.
Choi, Yoonseok, Ik‐Chan Song, Hyo Jin Lee, et al.. (2015). Expression and functional roles of the chemokine receptor CXCR7 in acute myeloid leukemia cells. Blood Research. 50(4). 218–218. 21 indexed citations
13.
Lee, Jong Wook, Jun Ho Jang, Je‐Hwan Lee, et al.. (2014). Ineffective Corticosteroid Treatment for Hemolysis Management of Paroxysmal Nocturnal Hemoglobinuria. Blood. 124(21). 5151–5151. 1 indexed citations
14.
Lee, Jong Wook, Jun Ho Jang, Je‐Hwan Lee, et al.. (2013). Clinical Signs and Symptoms In Non-Transfused Patients With Paroxysmal Nocturnal Hemoglobinuria From a Korean Prospective PNH Registry. Blood. 122(21). 3720–3720. 1 indexed citations
15.
Song, Ik‐Chan, et al.. (2011). Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases. The Korean Journal of Hematology. 46(2). 111–111. 34 indexed citations
16.
Cheong, June‐Won, Hoon Kook, Soo‐Mee Bang, et al.. (2007). The Clinical Guidelines for Myelodysplastic Syndrome. The Korean Journal of Hematology. 42(2). 71–71.
17.
Lee, Il-Kwon, Jeong‐Hwa Choi, Hee Nam Kim, et al.. (2006). Association of cis-Acting rs530 of the ETS2 Transcriptional Factor Gene with High-Risk Acute Myelogenous Leukemia (AML) and Allelic Expression Imbalance Assessment.. Blood. 108(11). 2230–2230. 1 indexed citations
18.
Na, Ki Ryang, et al.. (2006). A case of systemic lupus erythematosus associated with Hashimoto's thyroiditis and aplastic anemia. The Korean Journal of Internal Medicine. 70(6). 715–718.
19.
Hwang, Jinhee, Seong‐Woo Kim, Sang-Eun Park, et al.. (2006). Overexpression of Stromal Cell–derived Factor-1 Enhances Endothelium-supported Transmigration, Maintenance, and Proliferation of Hematopoietic Progenitor Cells. Stem Cells and Development. 15(2). 260–268. 16 indexed citations
20.
Feugier, Pierre, Na Li, Deog‐Yeon Jo, et al.. (2005). Osteopetrotic Mouse Stroma with Thrombopoietin, c-kit Ligand, and flk-2 Ligand Supports Long-Term Mobilized CD34 + Hematopoiesis In Vitro. Stem Cells and Development. 14(5). 505–516. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026